Key result
CCTA markers including indexed LAV >45 mL/m2 predict ~158% greater risk of post-stroke AF.
Why the study?
It is essential to identify stroke patients at highest risk of atrial fibrillation detected after stroke (AFDAS) to guide prolonged rhythm screening strategies, and the predictive value of atrial cardiopathy markers by cardiac-CT angiography (CCTA) on admission was not established.
Do atrial cardiopathy markers measured by cardiac-CT angiography predict atrial fibrillation detected after stroke in acute ischemic stroke patients?
Cohort (n=247)
No
Do atrial cardiopathy markers measured by cardiac-CT angiography predict atrial fibrillation detected after stroke in acute ischemic stroke patients?
Hazard Ratio: 2.58 (95% CI 1.19–5.62)
p-value: p=0.017
Adding cardiac-CT angiography to the acute stroke protocol identifies markers of atrial cardiopathy that independently predict the detection of atrial fibrillation after stroke, which may help guide rhythm screening strategies.
Cardiac CT markers may refine post-stroke AFDAS risk stratification beyond AS5F; leaves open prospective validation before guiding monitoring.
Introduction: Atrial fibrillation (AF) is one of the most common causes of ischemic stroke. It is essential to target patients at highest risk of AF detected after stroke (AFDAS), who should benefit from a prolonged rhythm screening strategy. Cardiac-CT angiography (CCTA) was added to the stroke protocol used in our institution in 2018. We sought to assess, for AFDAS, the predictive value of atrial cardiopathy markers by a CCTA performed on admission for acute ischemic stroke. Patients and Methods: From November 2018 to October 2019, consecutive stroke patients with no history of AF were included. Let atrial volume (LAV), epicardial adipose tissue (EAT) attenuation and volume, and LAA characteristics were measured on CCTA. The primary endpoint was the presence of AFDAS at follow-up, diagnosed by continuous electrocardiographic monitoring, long-term external Holter monitoring during hospital stay, or implantable cardiac monitor (ICM). Results: Sixty of the 247 included patients developed AFDAS. Multivariable analysis shows independent predictors of AFDAS: age >80 years (HR 2.46; 95%CI (1.23–4.92), p = 0.011), indexed LAV >45 mL/m2 (HR 2.58; 95%CI (1.19–5.62), p = 0.017), EAT attenuation > −85HU (HR 2.16; 95%CI (1.13–4.15), p = 0.021) and LAA thrombus (HR 2.50; 95%CI (1.06–5.93), p = 0.037). Added consecutively to AFDAS prediction AS5F score (combining age and NIHSS >5), these markers had an incrementally better predictive value compared with the global Chi2 of the initial model (p = 0.001, 0.035, and 0.015 respectively). Discussion and conclusion: Adding CCTA to the acute stroke protocol to assess markers of atrial cardiopathy associated with AFDAS may help to better stratify the AF screening strategy, including the use of an ICM.
No takes yet. Share an insight, caveat, or question.
Braillon et al. (2022) conducted a cohort in acute ischemic stroke (n=247). Cardiac-CT angiography (CCTA) markers of atrial cardiopathy was evaluated on presence of atrial fibrillation detected after stroke (AFDAS) at follow-up (HR 2.58, 95% CI 1.19-5.62, p=0.017). CCTA markers including indexed LAV >45 mL/m2 (HR 2.58; 95% CI 1.19-5.62) and LAA thrombus (HR 2.50) were independent predictors of atrial fibrillation detected after acute ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: